linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board of Directors  
Astrazeneca Pharma India Ltd.
 
BSE Code 506820
ISIN Demat INE203A01020
Book Value 332.64
NSE Code ASTRAZEN
Dividend Yield % 0.39
Market Cap 205837.50
P/E 102.46
EPS 80.36
Face Value 2  
ChairmanShilpa Divekar Nirula
Company SecretaryTanya Sanish
Executive DirectorPraveen Rao Akkinepally
Non Executive DirectorHooi-Bien Chuah
Non Executive Independent DirectorRevathy Ashok
Monica Widhani
Whole Time DirectorBhavana Agrawal
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.